FDA Expects Guidance On Validating Device Development Tools To Speed Approvals
This article was originally published in The Gray Sheet
A new FDA draft guidance establishes a voluntary process to validate publicly available device development tools so companies can routinely apply them to facilitate their path to market.
You may also be interested in...
Three years in the making, FDA has released a final guidance for medical device development tools that would allow developers to qualify their MDDTs and give medical device manufactures access to new tools that could help them prove safety and effectiveness of their products sooner.
At the Regulatory Affairs Professionals Society annual meeting last week, William Hawkins, chairman of the Medical Device Innovation Consortium, said the group is making progress in its first project on computer modeling and simulation, as well as future projects on clinical trial reform, and benefit-risk guidance and patient-centeredness.
The first public-private partnership to focus on promoting medical device regulatory science, known as the Medical Device Innovation Consortium, aims to speed up patient access to medical device technologies.